Organization
Mabion
2 clinical trials
Clinical trial
Randomized, Parallel-group, Double-blind, Comparative Bioequivalence Trial of MabionCD20 Compared to MabThera (Rituximab by Hoffman-La Roche) in Patients With Diffuse Large B-cell LymphomaStatus: Completed, Estimated PCD: 2017-08-01
Clinical trial
A Double-Blind, Randomized, Parallel-Group Study to Investigate the Pharmacokinetic and Clinical Similarity Between MabionCD20, EU-approved MabThera® and US-licensed Rituxan® in Patients With Moderate-to-Severe Rheumatoid ArthritisStatus: Withdrawn, Estimated PCD: 2023-08-03